Insights on Excellence in ADCs: check out the exclusive interviews with our dedicated team members, showcasing our state-of-the-art ADC manufacturing facilities and services. 🎥✨ At LOTTE BIOLOGICS, we pride ourselves on our cutting-edge technology and our team of ADC experts who oversee it. We would like to extend our heartfelt thanks to our experts, Mike Hausladen, Stephanie Wickham, Kern Chang (장건희), Ph.D., Pravin Pathak, Ph.D., and Kyle Bigness, for participating in this video and sharing their invaluable insights. Their extensive knowledge and experience enable us to deliver high-quality services and innovative solutions to our clients, helping them bring life-changing therapies to market. We invite you to watch the video and learn more about how LOTTE BIOLOGICS can support your ADC development needs. Together, we can make a difference in the world of biopharmaceuticals. 📺 Watch the full interview here: https://lnkd.in/grNsJUj6 #LOTTEBIOLOGICS #Biopharmaceuticals #ADC #AntibodyDrugConjugate #Antibody #Innovation #Quality #Partnership #LifeSciences
소개
Headquartered in Seoul, South Korea, LOTTE BIOLOGICS was founded in 2022 with a mission to deliver therapies that contribute to a healthier world. At the Syracuse Bio Campus in New York, LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes extensive analytical QC testing laboratories and warehouse facilities that have received over 62 regulatory approvals from agencies worldwide. LOTTE BIOLOGICS is also advancing into a new area of expertise with Antibody-Drug Conjugates (ADCs) services. With over $100 million invested in ADC modalities, including both drug substance and conjugation capabilities on-site, we offer a seamless, end-to-end service from drug substance manufacturing to conjugation. Looking ahead, LOTTE BIOLOGICS is constructing three advanced bio plants in Songdo, South Korea. With construction of the first plant already underway and expected to be operational by 2027, each facility will feature eight 15,000L stainless steel bioreactors for large-scale commercial production, along with multiple 3,000L bioreactors to meet clinical production needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity. Through our commitment to delivering innovative medicines to patients worldwide, LOTTE BIOLOGICS aims to become a top-tier global CDMO company in the biopharmaceutical industry.
- 웹사이트
-
https://www.lottebiologics.com/en
LOTTE BIOLOGICS 외부 링크
- 업계
- 제약
- 회사 규모
- 직원 501 - 1,000명
- 본사
- Seoul
- 유형
- 비상장기업
- 설립
- 2022
위치
LOTTE BIOLOGICS 직원
업데이트
-
LOTTE BIOLOGICS is gearing up for DCAT Week 2025 in New York City from March 17-20. We invite you to visit us at the Lotte New York Palace, Suite #4617. This is your chance to meet with our experts and discover how our cutting-edge biologics, ADC production, and CDMO services can elevate your business. Let's discuss innovative solutions and explore new opportunities in biopharma manufacturing together. Don't miss out on this opportunity to connect with us in the vibrant heart of NYC. Schedule your meeting with us today and be part of the future of biopharma! #DCATWeek2025 #LOTTEBIOLOGICS #Biopharma #Innovation #NYC
-
-
We are proud to announce that Brooke Jenkins, from our Syracuse Bio Campus, presented at the 2025 ISPE Aseptic Conference in Washington DC. Their session, "Navigating ADCs: Risk, Regulatory and Containment," covered key aspects of ADC manufacturing, including regulatory guidance and containment strategies. At LOTTE BIOLOGICS, our ADC facility, located in our Syracuse Bio Campus, enables us to offer top-tier ADC CDMO services. Congratulations to Brooke for showcasing our expertise on this prestigious platform! Want to learn more about LOTTE BIOLOGICS' ADC Services? Click the link below. https://lnkd.in/gJGEpXmz #LOTTEBIOLOGICS #ISPE2025 #AsepticConference #ADCs #CDMO
-
-
The construction of our Songdo Bio Campus is progressing as planned, with steady progress being made each day. 🚧 Plant 1 is set to commence operations in 2027 with a production capacity of 120,000L. To meet the increasing demand for high-titer biopharmaceuticals from our clients, we will be providing 4 trains of bioreactors with two 3,000L stainless steel bioreactors per train. If you are interested in learning more about our Songdo Bio Campus or our CDMO services, please feel free to reach out through our official website. https://lnkd.in/gxnWNESz Stay tuned for more updates and check out the latest construction progress in the video below! 🎥 #LOTTEBIOLOGICS #Biopharmaceutical #BioCampus #CDMO #AntibodyProduction #ADC
-
We are thrilled to announce our partnership with Asimov, a trailblazing company that combines synthetic biology and computational models to enable development of biologics and cell/gene therapies. Through this collaboration, LOTTE BIOLOGICS will provide even more innovative and integrated solutions to our clients, while Asimov will leverage our large-scale GMP manufacturing capabilities to enhance efficiency and reliability in the transition from cell line development to GMP production. Looking ahead, LOTTE BIOLOGICS and Asimov will continue exploring new client partnerships and strategic collaborations to expand our CDMO offerings. Stay with us as we strengthen our cell line development and GMP production capabilities to deliver high-quality biopharmaceuticals worldwide! #LOTTEBIOLOGICS #Asimov #CDMO #Biopharmaceutical #GMP #StrategicPartnership #Antibody #ADC
-
-
LOTTE BIOLOGICS is delighted to be named a finalist for the CenterState CEO 2025 Business of the Year Awards! 🎉 This recognition fuels our commitment to continued growth, exemplary leadership, and making a lasting difference in the community we serve. We appreciate the support and look forward to building on this momentum to achieve even greater success in the biopharmaceutical sector. #LOTTEBIOLOGICS #Biopharmaceutical #CenterStateCEO #BusinessOfTheYear #CommunityCommitment #BusinessLeadership
CenterState CEO today announced its finalists for its 2025 Business of the Year Awards! Three finalists were selected for each category from an outstanding and highly competitive pool of applicants reflecting the growth of the regional economy. These member businesses and organizations have achieved significant growth, exemplified business leadership and have gone above and beyond in their commitment to the community. Join CenterState CEO at its 2025 Annual Meeting on Wednesday, April 23, at the Oncenter, to celebrate all the finalists, and see who wins! Presented by Crouse Health, Equitable and Tompkins Community Bank. Register here: https://hubs.la/Q03bPH5y0 COMMUNITY INVOLVEMENT: AmeriCU Credit Union, Equitable and Upstate Medical University NONPROFIT: Loretto, Oswego County Federal Credit Union and YMCA of Central New York FEWER THAN 50 EMPLOYEES: Chimera Integrations, ConsciousHR and Home Sweet Home Cleaning LLC MORE THAN 50 EMPLOYEES: Hidden Level Inc., LOTTE BIOLOGICS and VIP Structures MINORITY-OWNED (In Partnership with the Upstate Minority Economic Alliance (UMEA) ): Champions Martial Arts, Inc., Cuse Culture Media Group and L Stacks Construction Co. LLC
-
-
LOTTE BIOLOGICS is proud to unveil our state-of-the-art ADC (Antibody-Drug Conjugate) manufacturing facility located within the Syracuse Bio Campus!🎉 This new facility positions us to offer a comprehensive, end-to-end service for ADC production, making us your go-to partner for all stages of ADC development. Under our vision, "From Antibody to Conjugate: Your US-based Single Source ADC Partner," LOTTE BIOLOGICS leverages over 18 years of expertise in antibody production and cutting-edge ADC manufacturing capabilities. We are committed to being a reliable and innovative partner for our potential clients. Discover more about our new ADC facility and how we can support your needs by watching our latest video: https://lnkd.in/dj3jGPKg #LOTTEBIOLOGICS #ADC #Biotech #Pharma #Innovation #SyracuseBioCampus #AntibodyProduction #Biomanufacturing #Pharmaceuticals #Biotechnology
-
We’re thrilled to be part of DCAT Week 2025, taking place from March 17-20 in New York City! Join us at the Lotte New York Palace, Suite #4617, to explore how our biologics, ADC production, and CDMO services can support your business. Don't miss this opportunity to connect and discuss innovative solutions in biopharma manufacturing. We look forward to meaningful discussions and new collaborations in the heart of NYC. See you there! #DCAT2025 #LOTTEBIOLOGICS #CDMO #ADC #OneStopService
-
-
LOTTE BIOLOGICS is thrilled to have attended the CNY Women's Summit alongside incredible leaders from around New York. The event was truly inspiring, offering valuable opportunities for networking, learning, and supporting our local community. Thank you to everyone who made this day so impactful. #CNYwomensnetwork #LOTTEBIOLOGICS #Networking #SupportLocal
Senior Scientist - Analytical Sciences and Technology at Lotte Biologics - Antibody Drug Conjugates
It was a great day attending the CNY women’s summit with my fantastic LOTTE BIOLOGICS colleagues. #CNYwomensnetwork #LOTTEBIOLOGICS #networking #supportlocal
-
-
This International Women's Day, we at LOTTE BIOLOGICS recognize and appreciate the experience, dedication and leadership of the women at our company who help drive our success every day. Across Finance, Marketing, Manufacturing and beyond, they bring invaluable skills, perspectives and contributions that strengthen our company and industry. On International Women's Day, we take a moment to celebrate their hard work and achievements. We at LOTTE BIOLOGICS remain committed to fostering an environment where everyone has the opportunity to thrive. #IWD2025 #InternationalWomensDay #WomenInScience #WomenInLeadership
-